Supplementary Appendix
|
|
- Moris York
- 5 years ago
- Views:
Transcription
1 Outcomes of adult patients with sickle cell disease admitted to the intensive care unit: a case series. Jérôme Cecchini, MD 1, François Lionnet, MD 2, Michel Djibré, MD 1, Antoine Parrot, MD 1, Katia Stankovic Stojanovic, MD 2, Robert Girot, MD PhD 3, and Muriel Fartoukh MD PhD 1. Supplementary Appendix
2 Data Collection Demographics, anamnestic data, and baseline characteristics Age, sex, body mass index, and dates of hospital and ICU admission were recorded. Baseline characteristics included the type of hemoglobinopathy (homozygous HbSS; compound heterozygous; co-existence of -thalassemia) and the steady-state laboratory values [hemoglobin (Hb), fetal hemoglobin (HbF), lactate dehydrogenase (LDH), serum creatinine and the estimated glomerular filtration rate (egfr) using the Modification of Diet in Renal Disease (MDRD)]. This information were obtained during routine visits distant by at least 1 month from an acute clinical event, and 3 months from a blood product transfusion, except for patients included in a blood transfusion program. The SCD-related organ damages recorded included retinopathy, cerebral vasculopathy, leg ulcer, priapism, avascular necrosis, cholelithiasis, microalbuminuria or proteinuria. History and frequency of painful crisis and ACS requiring hospitalization were recorded. The clinical severity of SCD was assessed on the clinical severity scoring system described by Hebbel et al. [1] (Table E1). Long-term treatments with folate supplementation, hydroxycarbamide, blood transfusion program, erythropoietin, or iron chelator were recorded. ICU and hospital stay Vital parameters, including heart and respiratory rates, blood pressure, pulse oximetry value and pain, were recorded on ICU admission. Pain was assessed using a visual analog scale ranging from 0 (no pain) to 10 (extremely severe pain). The worst values of the 48 hours preceding ICU admission were also recorded. Laboratory values on ICU admission and within the preceding 48 hours included white blood cell and platelet counts, hemoglobin value and its change from baseline, LDH, total bilirubin, aspartate (ASAT) and alanine (ALAT)
3 aminotransferase, prothrombin ratio and serum creatinine. The lowest value of HbS obtained after transfusion was recorded for homozygous SCD patients. Life-threatening events present on or developing during ICU admission included acute respiratory failure, shock, acute kidney injury (AKI), and MOF. The reasons for ICU admission and the associated organ failures were separated into SCD-related and unrelated events. SCD-related events included vaso-occlusive crisis (VOC), ACS, hyperhemolytic transfusion reaction, opioid overdose, and cerebro vascular events (stroke or seizure) [2-5]. Management Standard care included bed rest, supplemental oxygen, intravenous hydration (30 ml/kg/day), folate supplementation, analgesics and blood products transfusion, as needed [6]. Opioid analgesics administration consisted in intravenous morphine patient controlledanalgesia. Blood transfusions were more likely administered alone when anemia was pronounced, and combined with phlebotomy when hemoglobin level did not drop enough while the clinical condition worsened, with the correspondence of 300 ml of blood exsanguinated for 1 pack of blood product transfused. Antibiotics were administered anytime an infection was clinically suspected or confirmed. A definite diagnosis of infection was retained when bacteria, fungi or viruses were evidenced in blood, lower respiratory or urinary tracts samplings, or any normally sterile site. Routine microbiological samples included blood and urine samples if core temperature was > 38.5 C. Sputum, blinded protected telescoping catheter or bronchoalveolar lavage samples and urinary antigen tests for Legionella pneumophila and Streptococcus pneumoniae were obtained in case of ACS. Other microbiological samples were clinically guided.
4 Inhaled nitric oxide (ino) was used in case of severe ACS, or as part of enrolment in the inosta study, a randomised controlled trial testing the efficacy and safety of ino in patients with mild ACS (ClinicalTrials.gov Identifier NCT ). Results Of the 167 episodes referred to the ICU and the affiliated step-down unit, 29 were excluded from the analysis, because of missing data (n=3), organizational reasons (n=17) or planned postpartum monitoring (n=9). Altogether, 138 admissions were analyzed in 119 patients (Figure 1). Characteristics in the preceding 48 hours and on ICU admission The therapeutic management was similar between the 2 groups before ICU admission, consisting in pain control with morphine (83%), non-steroidal anti-inflammatory drugs (26%), steroids (4%), administration of antibiotics (66%), and venous thrombo-embolism prophylaxis (32%). Acute respiratory failure (n=68; 49%), shock (n=10; 7%), and AKI (n=14; 10%) were diagnosed in 74 episodes (54%) on ICU admission. ACS was the most frequent diagnosis on ICU admission (n=99; 72%), whereas it accounted for 20% of the initial diagnoses (Table 3). There were only 8 episodes unrelated to SCD, including postpartum haemorrhage (n=1), skin and soft tissue infection (n=1), influenza A(H1N1)v infection (n=1), Pneumocystis jirovecii pneumonia (n=1), vaginal bleeding (n=1), bronchospasm (n=1), and parapneumonic pleural effusion (n=2) (Table 3). An infection was microbiologically documented in 29 episodes (21%), more often in the CO group (n=10; 34%) than in the UCO group (n=18; 17%) (p=0.03). The most common infected sites were lung, blood and urines.
5 The three major pathogens were Streptococcus pneumoniae, Klebsiella pneumoniae and Escherichia coli (Table E3). Management and outcome Management and outcome (Table 4) Mechanical ventilation was administered to 25 episodes (18%), including 21 episodes with a diagnosis of ACS on ICU admission and 23 episodes with a final diagnosis of ACS (Figure E1). Vaso-active drugs were administered to 10 episodes (7%). Acute kidney injury (AKI) was diagnosed in 14 episodes (10%) on ICU admission, 10 of which required a renal replacement therapy (Table E4).
6 Table E1. Severity scoring system described by Hebbel et al.[1] and modified by Lee et al. [7] Clinical manifestations Severe painful crisis defined as acute painful event requiring hospital admission and morphine administration Central nervous system damage documented by MRI or MRA (and conventional arteriography) Proliferative retinopathy Leg ulceration Aseptic necrosis of bones documented by X-Ray and/or MRI Renal hemorrhage secondary to papillary necrosis ACS diagnosed on the basis of the association of thoracic pain, dyspnea, and pulmonary infiltrates on Chest-X-Ray Priapism Scoring Less than 1 per year: 0 point 1 to 2 per year: 1 point 3 to 5 per year: 2 points More than 5 per year: 3 points No lesion: 0 point Diagnosis of overt stroke, silent stroke, or cerebral vasculopathy: 2 points No lesion: 0 point Current or previous lesion: 1 point No lesion: 0 point Current or previous history of leg ulceration: 2 points No bone lesion: 0 point Aseptic necrosis: 2 points per lesion No episode: 0 point History of renal hemorrhage: 1 point No episode: 0 point History of documented ACS: 2 points per episode No history of priapism: 0 point History of stuttering or acute priapism: 1 point
7 Table E2. Within-group changes during the preceding 48 hours of ICU admission. Changes in clinical characteristics Uncomplicated Outcome, n=110 Values [median (IQR)] within the preceding 48 hrs of ICU admission P1 value Complicated Outcome, n=28 Values [median (IQR)] within the preceding 48 hrs of ICU admission P2 value All episodes, n=138 P3 value Heart rate (per min) 106 (93-120) / 98 (86-115) ( ) / 113 ( ) Systolic blood pressure (mm Hg) 120 ( ) / 122 ( ) ( ) / 120 ( ) Diastolic blood pressure (mm Hg) 69 (60-77) / 70 (60-80) (55-75) / 61 (58-75) Respiratory rate (per min) 28 (22-35) / 24 (18-30) (30-40) / 32 (24-40) Visual analog scale for pain (points) a 8 (7-10) / 6 (4-8) (7-9) / 4 (2-7) Temperature ( C) 38.5 ( ) / 37.8 ( ) ( ) / 37.9 ( ) Changes in laboratory values Hemoglobin (g/dl) 8.1 ( ) / 7.9 ( ) ( ) / 7.2 ( ) White cell count (10 9 /L) 16.7 ( ) / 16.2 ( ) ( ) / 16.4 ( ) Platelet count (10 9 /L) 319 ( ) / 295 ( ) ( ) / 210 ( ) Lactate dehydrogenase (IU/L) 557 ( ) / 563 ( ) ( ) / 914 ( ) Total bilirubin ( mol/l) 58 (36-91) / 51 (30-88) (36-105) / 76 (34-105) ASAT (IU/L) 56 (38-82) / 59 (37-94) (54-110) / 85 (49-267) ALAT (IU/L) 38 (26-53) / 37 (25-59) (22-56) / 40 (26-63) Prothrombin ratio (%) 80 (69-91) / 81 (66-89) (59-90) / 68 (46-89) Serum creatinine ( mol/l) 61 (48-71) / 57 (47-69) (53-111) / 68 (52-162) Values are indicating median (inter-quartile range). P values refer to within-group paired changes (P1: within Uncomplicated Outcome group; P2: within Complicated Outcome group) and overall changes (P3). a pain was assessed using a visual analog scale ranging from 0 (no pain) to 10 (extremely severe pain).
8 Table E3. Site of infection and pathogens involved in microbiologically documented episodes. Site of infection Pathogen No (%) Klebsiella pneumoniae 1 Candida albicans 1 Blood a Aeromonas caviae 1 Staphylococcus aureus 1 All 4 Streptococcus pneumoniae 5 Streptococcus anginosus (pleural effusion) 1 Klebsiella pneumoniae 2 Staphylococcus aureus 1 Gram-negative bacillus 1 Lower respiratory tract Stomatococcus mucilaginosus 1 Pseudomonas aeruginosa 2 Mucormycosis 1 Pneumocystis jirovecii 1 Influenza A virus 2 All 17 Escherichia coli 3 Urinary tract Klebsiella pneumoniae 2 Enterococcus faecalis 1 All 6 Streptococcus pneumoniae (meningitis) 1 Parvovirus B19 infection 2 Miscellaneous Cytomegalovirus infection 2 Cholecystitis 1 Klebsiella pneumoniae (sinusitis) 1 All 7 Values are indicating number (%). a including 1 catheter-related infection.
9 Table E4. Characteristics of episodes with AKI on ICU admission. All AKI episodes, n=14 No RRT, n=8 Preexisting renal abnormalities Microalbuminuria or proteinuria, n (%) 10 (71) 6 (75) 4 (67) Chronic renal insufficiency, n (%) 5 (36) 2 (25) 3 (50) AKI stages, n (%) a Baseline egfr, ml/min/1,73m 2, median (quartile) 99 (58-141) 125 (86-149) 87 (43-99) Stage 1 10 (71) 7 (88) 3 (50) Stage 2 2 (14) 0 (0) 2 (33) Stage 3 2 (14) 1 (13) 1 (17) Increase in serum creatinine, % b 160 ( ) 160 ( ) 200 ( ) Complicated outcome No (%) 10 (71) 4 (50) 6 (100) Need for organ support other than RRT, n (%) 8 (57) 4 (50) 4 (67) NSAIDs before ICU admission No (%) 3 (21) 2 (25) 1 (17) Values are indicating median (inter-quartile range) or number (%). Definition of abbreviations: AKI = acute kidney injury; egfr = estimated glomerular filtration rate; ICU = intensive care unit; NSAIDs = non-steroid anti-inflammatory drugs; RRT = renal replacement therapy. a AKI stage based on serum creatinine on ICU admission and defined as [8] stage 1: serum creatinine increase 26.4 µmol/l or serum creatinine increase from baseline %. stage 2: serum creatinine increase from baseline > %. stage 3: serum creatinine increase from baseline > 300% or serum creatinine 354 µmol/l with an acute increase of at least 44 µmol/l. b as compared with baseline serum creatinine value. RRT, n=6
10 Figure E1. Respiratory management of Acute Chest Syndrome in the intensive care unit. Abreviations: NIV, Non-invasive ventilation. Non-invasive ventilation was first administered to 20 episodes during ICU stay, 9 of which were secondarily intubated. NIV failure and success correspond to the need or not for subsequent tracheal intubation, respectively. Altogether, invasive ventilation was administered to 12 episodes (12%) for a median duration of 8 days (1-10).
11 References 1. Hebbel R.P., Boogaerts M.A., Eaton J.W., et al. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med, 1980, 302, p Adams R.J. Stroke prevention and treatment in sickle cell disease. Arch Neurol, 2001, 58, p Ballas S.K., Lieff S., Benjamin L.J., et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol, 2010, 85, p Ohene-Frempong K., Weiner S.J., Sleeper L.A., et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 1998, 91, p Petz L.D., Calhoun L., Shulman I.A., et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion, 1997, 37, p Lionnet F., Arlet J.B., Bartolucci P., et al. [Guidelines for management of adult sickle cell disease.]. Rev Med Interne, 2009, 30 Suppl 3, p.s Lee K., Gane P., Roudot-Thoraval F., et al. The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia. Blood, 2001, 98, p Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care, 2007, 11, p.r31
Health Maintenance and Education for Children and Adults
Health Maintenance and Education for Children and Adults Richard Ward, MSc, MRCP, FRCPath Director, Red Blood Cell Disorders Program, UHN Assistant Professor, Hematology, University of Toronto Chair, Canadian
More informationSickle Cell Disease. Edward Malters, MD
Sickle Cell Disease Edward Malters, MD Introduction Vaso-occlusive phenomena and hemolysis are the clinical hallmarks of Sickle Cell Disease (SCD) Inherited disorder due to homozygosity for the abnormal
More informationSickle cell disease. Fareed Omar 10 March 2018
Sickle cell disease Fareed Omar 10 March 2018 Physiology Haemoglobin structure HbA2: 2α and 2δ chains (2-3%) HbF: 2α and 2γ chains (
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for
More informationRationale for RBC Transfusion in SCD
Rationale for RBC Transfusion in SCD Dilution of HgbS-containing RBCs via the addition of HgbA-containing cells from the blood of normal donors Suppression of erythropoietin release caused by the rise
More informationOnline Supplement for:
Online Supplement for: INFLUENCE OF COMBINED INTRAVENOUS AND TOPICAL ANTIBIOTIC PROPHYLAXIS ON THE INCIDENCE OF INFECTIONS, ORGAN DYSFUNCTIONS, AND MORTALITY IN CRITICALLY ILL SURGICAL PATIENTS A PROSPECTIVE,
More informationHydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease
Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease A Pocket Guide for the Clinician Susan E. Creary, MD, MSc 1 John J. Strouse, MD, PhD 2 1 The Ohio State University School of
More informationISF criteria (International sepsis forum consensus conference of infection in the ICU) Secondary peritonitis
Appendix with supplementary material. This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Supplementary Tables Table S1. Definitions
More informationSICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN
SICKLE CELL DISEASE Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN Objective: The student should be able: To identify the presentation, diagnosis,
More informationCongenital Haemoglobinopathies
Congenital Haemoglobinopathies L. DEDEKEN, MD H O P I T A L U N I V E R S I T A I R E D E S E N F A N T S R E I N E F A B I O L A U N I V E R S I T E L I B R E DE B R U X E L L E S Red Blood Cell Disorders
More informationAcute Complications of Sickle Cell Disease
Management of Acute Complications of Sickle Cell Disease A Pocket Guide for the Clinician Timothy McCavit, MD, MSCS 1 Payal Desai, MD 1 University of Texas Southwestern Medical Center The Ohio State University,
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Blum CA, Nigro N, Briel M, et al. Adjunct prednisone
More informationHealthcare-associated infections acquired in intensive care units
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Healthcare-associated infections acquired in intensive care units Key facts In 2015, 11 788 (8.3%) of patients staying in an intensive care unit
More informationOriginal Research Article Ssafety and efficacy of prolonged hydroxycarbamide administration in adults with
1 1 2 3 Original Research Article Ssafety and efficacy of prolonged hydroxycarbamide administration in adults with sickle cell disease in Northwestern Greece 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
More informationAcute vaso-occlusive Pain in children
Acute vaso-occlusive Pain in children Dr François Angoulvant 1 Dr Sebastien Redant 2 Dr Malika Benkerrou 1 Pr Alina Ferster 2 Hôpital Robert Debré - Paris Hôpital des Enfants Reine Fabiola Bruxelles Réseau
More informationThe Management of Acute Chest Syndrome in Children with Sickle Cell Disease
The Management of Acute Chest Syndrome in Children with Sickle Cell Disease Document Information Version: 4 Date: Dec 2013 Authors (incl. job title): Professor David Rees and Dr Sue Height, consultant
More informationDependance on chronic transfusion
Dependance on chronic transfusion Pr Saliou Diop Hematology Blood transfusion Dakar- Sénégal diop@cnts-dakar.sn Introduction Chronic transfusion: Regular use of blood transfusion in patients with chronic
More informationPART II: PREVENTING AND MANAGING COMPLICATIONS OF SICKLE CELL DISEASE
PART II: PREVENTING AND MANAGING COMPLICATIONS OF SICKLE CELL DISEASE 1. PAIN Principles To educate patients, family and other caregivers about prevention, rapid identification and management of vaso-occlusive
More informationAnemia s. Troy Lund MSMS PhD MD
Anemia s Troy Lund MSMS PhD MD lundx072@umn.edu Hemoglobinopathy/Anemia IOM take home points. 1. How do we identify the condtion? Smear, CBC Solubility Test (SCD) 2. How does it present clincally? 3. How
More informationGuideline for the Management of Acute Chest Syndrome in Children with Sickle Cell Disease
Guideline for the Management of Acute Chest Syndrome in Children with Sickle Cell Disease Definition Acute chest syndrome (ACS) is defined as an acute illness characterized by fever and/or respiratory
More informationFull Case: Questions: What is sickle cell crisis?
Full Case: 30 y/o with avascular necrosis of her right hip was admitted for a total hip arthroplasty. Her hematocrit was 22%, blood pressure was 130/90 mm Hg, and pulse was 107 beats per minute. She had
More information4. Which survey program does your facility use to get your program designated by the state?
TRAUMA SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and
More informationCURRENT RESEARCH STUDIES
CURRENT RESEARCH STUDIES SCAGO SICKLE CELL RESEARCH DAY MAY 12, 2018 REBECCA LEROUX RN, BSCN, CCRP RED BLOOD CELL DISORDERS PROGRAM, UNIVERSITY HEALTH NETWORK MANUELA MERELLES-PULCINI RN, BSCN, MSN, CCRP
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Minniti CP, Gorbach AM, Xu D, et al. Topical
More informationEnhanced EARS-Net Surveillance 2017 First Half
1 Enhanced EARS-Net Surveillance 2017 First Half In this report Main results for 2017, first half Breakdown of factors by organism and resistance subtype Device-association Data quality assessment Key
More informationManaging Emergencies
Managing Emergencies Richard Ward, MSc, MRCP, FRCPath Director, Red Blood Cell Disorders Program, UHN Assistant Professor, Hematology, University of Toronto Chair, Canadian Hemoglobinopathy Association
More informationSupplementary Online Content
Supplementary Online Content Andrews B, Semler MW, Muchemwa L, et al. Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical
More informationHospital-acquired Pneumonia
Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired
More informationCompassionate-use Voxelotor (GBT440) for up to 2 Years in Patients With Severe Sickle Cell Disease and Life-Threatening Comorbidities
Compassionate-use Voxelotor (GBT440) for up to 2 Years in Patients With Severe Sickle Cell Disease and Life-Threatening Comorbidities Gershwin Blyden, MD 1, Kenneth Bridges, MD 2, Lanetta Bronté, MD 1
More informationHU: Myths and Facts. Melanie Kirby Associate Professor of Paediatrics
HU: Myths and Facts Melanie Kirby Associate Professor of Paediatrics SACGO Hamilton, Ontario March 5, 2016 Declaration of Disclosure I have no actual or potential conflict of interest in relation to this
More informationInfluenza-Associated Pediatric Deaths Case Report Form
STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Form approved OMB No. 0920-0007 Last Name: First Name: County: Address: City: State, Zip: Patient Demographics 1. State: 2. County: 3. State
More informationChapter 10 Respiratory System J00-J99. Presented by: Jesicca Andrews
Chapter 10 Respiratory System J00-J99 Presented by: Jesicca Andrews 1 Respiratory System 2 Respiratory Infections A respiratory infection cannot be assumed from a laboratory report alone; physician concurrence
More informationCommunity Acquired Pneumonia. Abdullah Alharbi, MD, FCCP
Community Acquired Pneumonia Abdullah Alharbi, MD, FCCP A 68 y/ male presented to the ED with SOB and productive coughing for 2 days. Reports poor oral intake since onset due to nausea and intermittent
More informationMedical Complications of Pregnancy
Medical Complications of Pregnancy Systems Cardiovascular Pulmonary Endocrine Gastrointestinal Urologic Neurologic Cardiovascular System Physiologic anemia 3:1 increase of plasma volume:rbc mass Treat
More informationDefinitions. You & Your New Transplant ` 38
Definitions Acute Short, relatively severe Analgesic Pain medicine Anemia A low number of red blood cells Anesthetic Medication that dulls sensation in order to reduce pain Acute Tubular Necrosis (ATN)
More informationACUTE KIDNEY INJURY (AKI) ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ADVANCED DIRECTIVE LIMITING CARE...91 AGE...9 AGE UNITS...
ACUTE KIDNEY INJURY (AKI)...122 ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)...124 ADVANCED DIRECTIVE LIMITING CARE...91 AGE...9 AGE UNITS...10 AIRBAG DEPLOYMENT...30 AIS PREDOT CODE...118 AIS SEVERITY...119
More informationANWICU knowledge
ANWICU knowledge www.anwicu.org.uk This presenta=on is provided by ANWICU We are a collabora=ve associa=on of ICUs in the North West of England. Permission to provide this presenta=on has been granted
More informationInfluenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No
Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No. 0920-0004 STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Last Name: First Name: County: Address: City: State,
More informationSupplementary Online Content
Supplementary Online Content Uranga A, España, Bilbao A, et al. Duration of antibiotic treatment in communityacquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med. ublished online
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY
HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health
More informationAtlantic Provinces Pediatric Hematology Oncology Network Réseau d Oncologie et Hématologie Pédiatrique des Provinces Atlantiques
Atlantic Provinces Pediatric Hematology Oncology Network Réseau d Oncologie et Hématologie Pédiatrique des Provinces Atlantiques 5850/5980 University Avenue, PO Box 9700 Halifax, NS, B3K 6R8 1.902.470.7429
More informationData Collection Tool. Standard Study Questions: Admission Date: Admission Time: Age: Gender:
Data Collection Tool Standard Study Questions: Admission Date: Admission Time: Age: Gender: Specifics of Injury: Time of Injury: Mechanism of Injury Blunt vs Penetrating? Injury Severity Score? Injuries:
More informationSupplementary Online Content
Supplementary Online Content Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory
More informationCompassionate-use Experience With Voxelotor (GBT440) for Patients With Severe Sickle Cell Disease (SCD) and Life-Threatening Comorbidities
Compassionate-use Experience With Voxelotor (GBT440) for Patients With Severe Sickle Cell Disease (SCD) and Life-Threatening Comorbidities Gershwin Blyden, MD 1, Kenneth R. Bridges, MD 2, Lanetta Bronté,
More informationCommunity-Acquired Pneumonia OBSOLETE 2
Community-Acquired Pneumonia OBSOLETE 2 Clinical practice guidelines serve as an educational reference, and do not supersede the clinical judgment of the treating physician with respect to appropriate
More informationCASE 5 - Toy et al. CASE FILES: Obstetrics & Gynecology
z CASE 5 - Toy et al. CASE FILES: Obstetrics & Gynecology A 28-year-old woman is brought into the emergency room with a blood pressure of 60/40. The patient s husband states that she had 2 days of nausea
More informationSevere β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy
Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.
More informationLong Term Effects of Hydroxyurea on Adult Patients with Sickle Cell Anemia
St. Catherine University SOPHIA Master of Arts in Nursing Theses Nursing 12-2012 Long Term Effects of Hydroxyurea on Adult Patients with Sickle Cell Anemia Christine R. Reimer St. Catherine University
More informationSupplementary Online Content
Supplementary Online Content Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al. Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children
More informationHow to Write a Life Care Plan for a Child with Hemoglobinopathy
How to Write a Life Care Plan for a Child with Hemoglobinopathy Tamar Fleischer, BSN, MSN, CNLCP & Mona Yudkoff, RN, MPH, CRRN, CNLCP BalaCare Solutions March 2018 St. Peterburg, Florida What is Hemoglobinopathy?
More informationNatural History Of Tricuspid Regurgitant Jet Velocity And A New Association With Proteinuria In Children With Sickle Cell Disease
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2013 Natural History Of Tricuspid Regurgitant Jet Velocity
More informationSurveillance of Healthcare Associated Infections in Scottish Intensive Care Units
Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units Annual report of data from January 2010 to December 2010 Scottish Intensive Care Society Audit Group 1 Health Protection
More informationFamily Centered Pediatric Emergency Department Sickle Cell Assessment of Needs and Strengths (FC-Peds-ED-SCANS) Overall Algorithm
Family Centered Pediatric Emergency Department Sickle Cell Assessment of Needs and Strengths (FC-Peds-ED-SCANS) Overall Algorithm Decision 1: Triage Decision 2: Analgesic Management Decision 3: Diagnostic
More informationPFIZER INC. Study Center(s): A total of 6 centers took part in the study, including 2 in France and 4 in the United States.
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.
More informationAPPENDIX EXHIBITS. Appendix Exhibit A2: Patient Comorbidity Codes Used To Risk- Standardize Hospital Mortality and Readmission Rates page 10
Ross JS, Bernheim SM, Lin Z, Drye EE, Chen J, Normand ST, et al. Based on key measures, care quality for Medicare enrollees at safety-net and non-safety-net hospitals was almost equal. Health Aff (Millwood).
More informationFluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)
Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI) Robert W. Schrier, MD University of Colorado School of Medicine Denver, Colorado USA Prevalence of acute renal failure in Intensive
More informationPediatric Red Cell Exchange Indications, Benefits, Barriers. View from California Saturday May 9 th ASFA 2015
Pediatric Red Cell Exchange Indications, Benefits, Barriers View from California Saturday May 9 th ASFA 2015 Red Cell Exchange: Not SCD Recommendations for Red Cell Exchange Indication Procedure Recommendation
More informationAcute Chest Syndrome In A Patient With Sickle Cell Anemia Successfully Treated With Erythrocytapheresis
ISPUB.COM The Internet Journal of Emergency and Intensive Care Medicine Volume 9 Number 2 Acute Chest Syndrome In A Patient With Sickle Cell Anemia Successfully Treated With A Kararmaz, O Ayyildiz, S Kaya,
More informationAcute Comorbidity Categories
ESRD PPS Comorbidity Categories and Diagnosis Codes Crosswalk Gastrointestinal Bleeding 530.21 Ulcer of esophagus with bleeding 531.00 Acute gastric ulcer with, without mention of Acute Comorbidity Categories
More informationPneumonia. Definition of pneumonia Infection of the lung parenchyma Usually bacterial
Pneumonia Definition of pneumonia Infection of the lung parenchyma Usually bacterial Epidemiology of pneumonia Commonest infectious cause of death in the UK and USA Incidence - 5-11 per 1000 per year Worse
More informationThe following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS.
Page 1 The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS. Appendix TABLE E-1 Care-Module Trigger Events That May Indicate an Adverse
More informationCOHEM Barcellona 2012 Hemoglobinopathies debate
COHEM Barcellona 2012 Hemoglobinopathies debate September 8, 2012: h. 10:30-12:00 Hall: A Is it justified to perform BMT in hemoglobinopathies using unrelated and/or partially mismatched donors? HSCT indication
More informationSickle Cell Disease and impact on the society
Sickle Cell Disease and impact on the society Professor Z.A.Jeremiah Ph.D, FRCPath (London) Professor of Haematology and Blood Transfusion Science Niger Delta University, Wilberforce Island Outline What
More informationEarly detection. Proactive intervention.
Early detection. Proactive intervention. 70% Central Venous Catheter Edwards oximetry central venous catheter (CVC) the first proven CVC with continuous monitoring reveals the true adequacy of tissue oxygenation
More informationSurveillance of Healthcare Associated Infections in Scottish Intensive Care Units
Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units Annual report of data from January 2011 to December 2011 Scottish Intensive Care Society Audit Group Health Protection
More informationMinimal doses of hydroxyurea for sickle cell disease
Brazilian Journal of Medical and Biological Research (1997) 30: 933-940 Minimal HU doses for sickle cell disease ISSN 00-79X 933 Minimal doses of hydroxyurea for sickle cell disease C.S.P. Lima, V.R. Arruda,
More informationSURVEILLANCE BLOODSTREAM INFECTIONS IN BELGIAN HOPITALS ( SEP ) RESULTS ANNUAL REPORT data
SURVEILLANCE BLOODSTREAM INFECTIONS IN BELGIAN HOPITALS ( SEP ) RESULTS ANNUAL REPORT data 2000-2014 SEP Workgroup Meeting 24 June 2015 Dr. Naïma Hammami Dr. Marie-Laurence Lambert naima.hammami@wiv-isp.be
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)
Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Mortality Measures Set
More informationHigh Hemoglobin F in a Saudi Child Presenting with Pancytopenia
Case Report imedpub Journals http://www.imedpub.com Journal of Pediatric Care ISSN 2471-805X DOI: 10.21767/2471-805X.100002 High Hemoglobin F in a Saudi Child Presenting with Pancytopenia Abstract Saudi
More informationLecture Notes. Chapter 9: Smoke Inhalation Injury and Burns
Lecture Notes Chapter 9: Smoke Inhalation Injury and Burns Objectives List the factors that influence mortality rate Describe the nature of smoke inhalation and the fire environment Recognize the pulmonary
More informationPutting some hematology into Pediatric Hematology/Oncology: a review of Hemophilia and Sickle Cell Disease in the Pediatric Patient
Putting some hematology into Pediatric Hematology/Oncology: a review of Hemophilia and Sickle Cell Disease in the Pediatric Patient Kristina Haley, DO March 10, 2012 Jovita Reyes Memorial Pediatric Hematology/Oncology
More informationUpper...and Lower Respiratory Tract Infections
Upper...and Lower Respiratory Tract Infections Robin Jump, MD, PhD Cleveland Geriatric Research Education and Clinical Center (GRECC) Louis Stokes Cleveland VA Medical Center Case Western Reserve University
More informationLecture Notes. Chapter 16: Bacterial Pneumonia
Lecture Notes Chapter 16: Bacterial Pneumonia Objectives Explain the epidemiology Identify the common causes Explain the pathological changes in the lung Identify clinical features Explain the treatment
More informationPredictors of Cerebral Blood Flow Velocity in Children with Sickle Cell Anaemia in Lagos State, Nigeria
Predictors of Cerebral Blood Flow Velocity in Children with Sickle Cell Anaemia in Lagos State, Nigeria Motunrayo Oluwabukola Adekunle 1*, Ijeoma Nnenna Diaku-Akinwumi 1, Adeola Barakat Animasahun 1, Olisamedua
More informationEnhanced EARS-Net Surveillance REPORT FOR 2012 DATA
Enhanced EARS-Net Surveillance REPORT FOR DATA 1 In this report Main results for Proposed changes to the enhanced programme Abbreviations Used Here BSI Bloodstream Infections CVC Central Venous Catheter
More informationSECTION 1: INCLUSION, EXCLUSION & RANDOMISATION INFORMATION
SECTION 1: INCLUSION, EXCLUSION & RANDOMISATION INFORMATION DEMOGRAPHIC INFORMATION Given name Family name Date of birth Consent date Gender Female Male Date of surgery INCLUSION & EXCLUSION CRITERIA YES
More informationQ1 Contact Information
Q1 Contact Information Answered: 7 Skipped: 0 ANSWER CHOICES Hospital Name of Person Completing Survey Email RESPONSES 100.00% 7 100.00% 7 100.00% 7 # HOSPITAL DATE 1 Saint Luke's Hospital of Kansas City
More informationSICKLE CELL DISEASE TO TREAT OR
SICKLE CELL DISEASE TO TREAT OR NOT TO TREAT COHEM Barcelona September 8, 2012 Sujit Sheth, M.D. Pediatric Hematology Oncology Disclosures None Outline Morbidity and mortality Definitive therapies Risk
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response
More informationAXITAB-CV TAB. COMPOSITION :
AXITAB-CV TAB. COMPOSITION : Each film coated tablet contains: Cefuroxime Axetil I.P. Eq. to Anhydrous 500mg. Potassium Clavulanate Diluted I.P. Eq. to Clavulanic Acid 125mg DESCRIPTION : Cefuroxime Axetil
More informationHbSC disease is it different and how should we manage it? David Rees Department of Paediatric Haematology, King s College Hospital, London
HbSC disease is it different and how should we manage it? David Rees Department of Paediatric Haematology, King s College Hospital, London Different types of sickle cell disesease Severe sickle cell disease
More informationAcute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)
Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a) Introduction The majority of acute painful crises in patients with sickle cell disease will be managed independently
More informationInstructor s Manual Chapter 26 Hematological Alterations. 1. A man and woman both test positive for the sickle cell trait. The couple asks the
1 Instructor s Manual Chapter 26 Hematological Alterations Answers to Study Questions 1. A man and woman both test positive for the sickle cell trait. The couple asks the nurse how many of their children
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationStaging Sepsis for the Emergency Department: Physician
Staging Sepsis for the Emergency Department: Physician Sepsis Continuum 1 Sepsis Continuum SIRS = 2 or more clinical criteria, resulting in Systemic Inflammatory Response Syndrome Sepsis = SIRS + proven/suspected
More informationPEACEHEALTH LABORATORIES
360-414-2306 www.peacehealthlabs.org Critical Values Call List - Longview Critical values are reported per the criteria published below. Laboratory results meeting these criteria indicate potential life-threatening
More informationCharles Feldman. Charlotte Maxeke Johannesburg Academic Hospital University of the Witwatersrand
Opportunistic Infections Community Acquired Pneumonia Charles Feldman Professor of Pulmonology and Chief Physician Charlotte Maxeke Johannesburg Academic Hospital University of the Witwatersrand Introduction
More informationCitation for published version (APA): van Tuijn, C. F. J. (2018). Sickle cell disease: Evaluation and management of disease burden.
UvA-DARE (Digital Academic Repository) Sickle cell disease van Tuijn, C.F.J. Link to publication Citation for published version (APA): van Tuijn, C. F. J. (2018). Sickle cell disease: Evaluation and management
More informationMedical and Surgical Complications of Sickle Cell Anemia
Medical and Surgical Complications of Sickle Cell Anemia Ahmed Al-Salem Medical and Surgical Complications of Sickle Cell Anemia Ahmed Al-Salem Department of Surgery Dar A lalafia Medical Company Qatif
More informationOnline Supplementary Data. Country Number of centers Number of patients randomized
A Randomized, Double-Blind, -Controlled, Phase-2B Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients with Sepsis and Suspected Disseminated Intravascular
More informationTrial protocol - NIVAS Study
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Trial protocol - NIVAS Study METHODS Study oversight The Non-Invasive Ventilation after Abdominal Surgery
More informationSINGLE. Efficacy and safety of dolutegravir (DTG) in treatment-naïve subjects
SINGLE Efficacy and safety of dolutegravir (DTG) in treatment-naïve subjects SE/HIV/0023/14 January 2014 PHASE III DTG TRIALS IN TREATMENT-NAÏVE ADULT SUBJECTS WITH HIV SINGLE 1 N=833 Phase III non-inferiority,
More informationImportant clinical and laboratory correlates of glomerular filtration rate in sickle cell anemia
Original Article Important clinical and laboratory correlates of glomerular filtration rate in sickle cell anemia AJ Madu, A Ubesie 1, S Ocheni, J Chinawa 1, KA Madu 2, OG Ibegbulam, C Nlemadim 3, A Eze
More informationManagement of Acute Exacerbations
15 Management of Acute Exacerbations Cenk Kirakli Izmir Dr. Suat Seren Chest Diseases and Surgery Training Hospital Turkey 1. Introduction American Thoracic Society (ATS) and European Respiratory Society
More informationPNEUMONIA IN CHILDREN. IAP UG Teaching slides
PNEUMONIA IN CHILDREN 1 INTRODUCTION 156 million new episodes / yr. worldwide 151 million episodes developing world 95% in developing countries 19% of all deaths in children
More informationBlood cultures in ED. Dr Sebastian Chang MBBS FACEM
Blood cultures in ED Dr Sebastian Chang MBBS FACEM Why do we care about blood cultures? blood cultures are the most direct method for detecting bacteraemia in patients a positive blood culture: 1. can
More informationTreatment of febrile neutropenia in patients with neoplasia
Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece
More informationPneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention. Basics of Infection Prevention 2-Day Mini-Course 2016
Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention Basics of Infection Prevention 2-Day Mini-Course 2016 Objectives Differentiate long term care categories of respiratory infections
More information